A Higher Dosage of Oral Alendronate Will Increase the Subsequent Cancer Risk of Osteoporosis Patients in Taiwan: A Population-Based Cohort Study

BACKGROUND: Controversy still exists regarding whether alendronate (ALN) use increases the risk of esophageal cancer or breast cancer. METHODS: This paper explores the possible association between the use of oral ALN in osteoporosis patients and subsequent cancer risk using the National Health Insur...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lee, Wen-Yuan, Sun, Li-Min, Lin, Ming-Chia, Liang, Ji-An, Chang, Shih-Ni, Sung, Fung-Chang, Muo, Chih-Hsin, Kao, Chia-Hung
Format: Artigo
Sprache:Inglês
Veröffentlicht: Public Library of Science 2012
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3534103/
https://ncbi.nlm.nih.gov/pubmed/23300854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0053032
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge